What Insurance Does a Digital Pathology Company Need?

More than one category of policy, because a digital pathology company is three businesses at once. It is a software vendor. It is a medical device maker when its tools help interpret a slide. It is a clinical services provider when pathologists read and report through its platform. A program that files the company under only one of those leaves the other two exposed, and the gaps usually sit exactly where the company is most novel.

Three Businesses, Three Exposures

The software side carries technology errors and omissions and cyber exposure: a platform outage, a defect, a breach of the images and patient data it holds. The device side appears the moment the platform does more than display, for example when an algorithm flags or measures a region and influences a diagnosis, which pulls it toward product liability and the overlap between Tech E&O and products liability. The clinical side is professional liability: a diagnostic error in what was read and reported. One company, three different claims, each answered by a different line. For a platform focused on cervical and other screening cytology, that same logic narrows to what a digital cytology platform needs.

Where Brokers Get It Wrong

The common mistake is placing the company as one thing. Treated as a software startup, it gets tech E&O and cyber but misses the diagnostic and product exposure. Treated as a lab, it gets professional liability but misses the software and product side. The sharpest version is the AI analysis itself, where the same feature is at once a software function, a device output, and an input to clinical judgment. That is the same continuously-updating exposure behind AI-powered device product liability, and it does not fit neatly in any single category.

The result is a program that looks complete on a certificate and has a hole exactly where the company is most innovative. A digital pathology company rarely fails to insure anything. It usually insures one of its three identities well and the other two by accident, and accidental coverage is the kind that disappears when a claim tests it. The exposures are not theoretical: the platform can go down, the algorithm can mislead a reader, and the final report can be wrong, and a single incident can involve more than one of those at once. A useful test is to take each policy in the program and ask which of the three businesses it is actually insuring, then check whether the other two have anything that would answer. Where the answer is nothing, that is the gap a claim will find first.

The Core Program

A digital pathology company usually needs professional liability for the diagnostic work, technology E&O and product liability coordinated for the platform and its algorithms, and cyber with HIPAA in mind for the image and patient data it holds, the same data discipline behind cyber and HIPAA coverage for clinical labs. Management liability follows once there is outside capital. The point is not more policies for their own sake. It is that each of the company’s three identities has a claim that only its matching line will answer.

What to Do Now

Map the company against all three identities and ask, for each, what claim it could face and which policy responds. Pay closest attention to the seams, where the algorithm meets the diagnosis and where the platform meets the data, because that is where a single-category placement leaves a hole. Build the program to the full coverage picture a clinical lab assembles plus the software and device lines the platform adds.

Before your next renewal, have the program reviewed as a software, device, and clinical business at the same time rather than one of the three. A specialty review through Tower Street Insurance can confirm a digital pathology company is covered across all three of the things it actually is.